Cointime

  • 最新情報
  • ニュース
  • 通貨
  • Columns
  • イベント
  • Bitcoin $91,726.38 +2.19%
  • Ethereum $3,141.47 +2.93%
  • BNB $904.93 +1.38%
  • Optimism $0.32 -0.51%
  • Arbitrum $0.21 +1.58%
  • Solana $136.04 +2.24%
  • Polygon $0.22 +2.77%
  • Cosmos $2.22 -2.08%
  • Avalanche $13.83 +2.77%
  • Bitcoin $91,726.38 +2.19%
  • Ethereum $3,141.47 +2.93%
  • BNB $904.93 +1.38%
  • Optimism $0.32 -0.51%
  • Arbitrum $0.21 +1.58%
  • Solana $136.04 +2.24%
  • Polygon $0.22 +2.77%
  • Cosmos $2.22 -2.08%
  • Avalanche $13.83 +2.77%
Home / EpimAb Biotherapeutics / investors

EpimAb Biotherapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
16
EpimAb Biotherapeutics is funded by 16 investors. MiraeAsset Financial Group and CMB International Capital Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
MiraeAsset Financial Group Yes Series C
CMB International Capital Corporation Yes Series C
Oriza Seed Capital (Oriza Yuandian) Yes Series A
Hidragon Capital - Series C
Adrian Cheng - Series C
Cormorant Asset Management - Series C
Decheng Capital - Series C
Hony Capital - Series C
Octagon Capital Advisors - Series C
SDIC Fund Management - Series C
Shangbay Capital - Series C
Sherpa Venture Capital - Series C
Yanchuang Capital - Series C
South China Venture Capital - Series B
3E Bioventures - Series A
Trend Investment Group - Series A

Contact

Shanghai,Shanghai,China
+49 (0) 15226107621
Cointime
Content
  • 最新情報
  • スタートアップ
  • 業界ニュース
  • テクノロジー
  • イベント
Company
  • 会社概要
  • 広告
  • 免責事項
  • © 2023 Cointime. 無断転載禁止
  • プライバシーポリシー
  • 利用規約